MILIND JAVLE to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications MILIND JAVLE has written about Xenograft Model Antitumor Assays.
Connection Strength
0.141
-
LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy. Oncotarget. 2015 May 10; 6(13):10940-9.
Score: 0.071
-
Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer. Br J Cancer. 2015 Mar 17; 112(6):1042-51.
Score: 0.070